Drug intelligence / Profile preview

autologous induced islet body

Development stage
Phase 1
Lead developer
Allife Medical Science and Technology
Modality
Cell Therapies
Administration
Other
01

Overview

Autologous induced islet body is an experimental cell therapy being developed by Allife Medical Science and Technology Co., Ltd. for the treatment of type 1 diabetes mellitus. The therapy involves the generation of islet-like clusters (islet bodies) from a patient's own cells, which are then transplanted back into the patient, specifically under the diaphragm in clinical trial protocols. This autologous approach is designed to restore endogenous insulin production and glycemic control while potentially avoiding the immune rejection and the need for chronic immunosuppression typically associated with allogeneic islet transplantation. The therapy is currently being evaluated in early-stage clinical trials to assess its safety and efficacy in adults with type 1 diabetes.

Other names
islet bodyautologous induced islet-like cells

Beyond the preview

Go deeper on autologous induced islet body.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous induced islet body.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call